BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28705035)

  • 1. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex.
    Shusterman M; Golub E; Mowrey WB; Broder A
    Lupus; 2018 Feb; 27(2):319-326. PubMed ID: 28705035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood groups and risk of deep venous thromboembolism in Chinese Han population from Chaoshan region in South China.
    Yu M; Wang C; Chen T; Hu S; Yi K; Tan X
    Saudi Med J; 2017 Apr; 38(4):396-399. PubMed ID: 28397946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
    Nascimento NM; Bydlowski SP; Soares RP; de Andrade DC; Bonfá E; Seguro LP; Borba EF
    J Thromb Thrombolysis; 2015 Oct; 40(3):374-8. PubMed ID: 25638331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid cancer, antiphospholipid antibodies, and venous thromboembolism.
    Font C; Vidal L; Espinosa G; Tàssies D; Monteagudo J; Farrús B; Visa L; Cervera R; Gascon P; Reverter JC
    Autoimmun Rev; 2011 Feb; 10(4):222-7. PubMed ID: 20955822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
    Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
    Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
    Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evolution in women with positive antiphospholipid antibodies.
    Riancho-Zarrabeitia L; Daroca G; Muñoz P; López-Hoyos M; Haya A; Martínez-Taboada VM
    Semin Arthritis Rheum; 2017 Dec; 47(3):397-402. PubMed ID: 28576307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large Artery Dysfunction in Primary Antiphospholipid Syndrome.
    Osmundo GS; Carvalho JF; Bortolotto LA; Viana VST; Bonfá E
    J Clin Rheumatol; 2018 Jan; 24(1):14-17. PubMed ID: 29200023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
    Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy.
    Bhanvadia S; Kazerouni K; Bazargani ST; Miranda G; Cai J; Daneshmand S; Djaladat H
    World J Urol; 2019 Jan; 37(1):173-179. PubMed ID: 29876671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism.
    Gary T; Belaj K; Bruckenberger R; Hackl G; Hafner F; Froehlich H; Zebisch A; Pilger E; Brodmann M
    Obesity (Silver Spring); 2013 Sep; 21(9):E463-6. PubMed ID: 23671009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.
    Pengo V; Ruffatti A; Legnani C; Testa S; Fierro T; Marongiu F; De Micheli V; Gresele P; Tonello M; Ghirarduzzi A; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    Blood; 2011 Oct; 118(17):4714-8. PubMed ID: 21765019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors.
    Vasan SK; Rostgaard K; Majeed A; Ullum H; Titlestad KE; Pedersen OB; Erikstrup C; Nielsen KR; Melbye M; Nyrén O; Hjalgrim H; Edgren G
    Circulation; 2016 Apr; 133(15):1449-57; discussion 1457. PubMed ID: 26939588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome.
    Del Ross T; Ruffatti A; Cuffaro S; Tonello M; Calligaro A; Favaro M; Facchinetti M; Hoxha A; Punzi L
    Thromb Res; 2015 Nov; 136(5):883-6. PubMed ID: 26410418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis.
    Kenet G; Aronis S; Berkun Y; Bonduel M; Chan A; Goldenberg NA; Holzhauer S; Iorio A; Journeycake J; Junker R; Male C; Manco-Johnson M; Massicotte P; Mesters R; Monagle P; van Ommen H; Rafini L; Simioni P; Young G; Nowak-Göttl U
    Semin Thromb Hemost; 2011 Oct; 37(7):802-9. PubMed ID: 22187403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood group influences risk of venous thromboembolism and myocardial infarction.
    Pang H; Zong Z; Hao L; Cao Q
    J Thromb Thrombolysis; 2020 Aug; 50(2):430-438. PubMed ID: 31820263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.